Open Letter to the Chancery Judge: To some inve

Open Letter to the Chancery Judge:

To some investors, Leronlimab is something that could have saved their loved one from death. Whether it be Cancer, or a COVID-19 patient in critical condition.

To some investors, Leronlimab would improve the quality of life or give them their life back from the aftereffects of COVID-19 - (Long Haulers).

To some investors, it’s about guarding the molecule and making sure it’s sees the the day of light at its obvious combo-therapy and max Mono-therapy potential.

I’ve read peers on social media say they had to let their loved one go because their parent was on a ventilator for more than a month and that they had to say good bye the next day.

…I didn’t have the heart to tell them about an amazing drug that wasn’t available yet.

But Ill never have the heart to say that a hostile group took over the molecule by lying and that’s why it might not ever be available.

See, I’ve read the proxy group say something in an SEC filing and then go on video and see them saying another. I’ve lost count how many times they have done this and continue to do so.

We are now facing the worst pandemic ever recorded in history and the molecule that could potentially end it… is facing a potential vote by who should be in charge of it.

In the middle of a pandemic a nominated Proxy Board member (Bruce Patterson) left a contractual agreement from CytoDyn and instead tried to patent the data for his company and himself from Intellectual Property he had no right to.

That same board member having zero clinical experience is now made to believe that he is the hero of this outcome and says things that sound good in hindsight.

The truth is; every presentation, plan, or condescending judgment made by the proxy group is seen as destructive by the very core of our share holders. Our core share holders are retail, everyday life people that believe justice will prevail.

The argument the proxy group will be is; allow share holders to have a choice.
-Unfortunately, they withheld pertinent info from our choice and I suspect they’re hiding more.

Their argument will be that they understand the science better and will see the molecule across the finish line.
-Unfortunately, they can’t even be compliant with the SEC. The tests that they tout as an IncellDx specialty have been around for years before the company was ever founded.

Lastly, their argument will be that they won’t dilute our value as share holders, when in fact, they have hurt our stock more with each litigation the company had judiciary duty to defend, past, present or even future.

I would much rather focus on the bright future we have with a molecule that has over 31 indications and what it will mean for mankind, or even you and your family.

I rather do that than witness a small group of disgruntled ex employees plot with insider intelligence and impatient share holders to enrich themselves.

Thank you,
Not only a concerned investor, but a concerned person